BioMarin Pharmaceutical Inc. Financial Ratios — BMRN Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-7.22	-12.78	-14.97	-9.34	-8.75	-24.39	-4.2	-2.67	-0.78	23.63	-1.53	3.19	3.51	8.05	5.94
Return on Assets (%)	-4.19	-7.96	-9.25	-5.68	-5.54	-16.26	-2.7	-1.7	-0.52	16.21	-1.08	2.29	2.54	6.17	4.79
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.8	3.12	7.1	5.51
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.75	2.81	6.19	4.57
Gross Margin (%)	80.96	81.66	83.88	83.68	82.92	81.23	81.59	78.86	78.91	71.82	74.52	76	78.01	79.67	77.73
EBITDA Margin (%)	0.26	-13.16	-21.88	-6.28	-7.14	-63.26	5.57	-1.87	0.28	3.32	1.39	12.54	11.99	20.35	15.18
Operating Margin (%)	-7.68	-22.01	-28.27	-21.41	-31.63	-18.29	-10.63	-10.4	-6.15	-4.94	-4.03	2.74	7.68	16.62	12.71
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	34.01	32.83	- -	23.6	8.31	- -	52.75	39.72	66.36	- -
Pretax Margin (%)	-9.88	-23.62	-32.18	-16.66	-17.39	-74.41	-2.73	-9.57	-5.56	-2.63	-4.08	7.14	7.79	18.98	14.98
Profit Margin (%)	-12.2	-22.84	-32.15	-17.88	-19.31	-56.43	-8.91	-5.18	-1.4	45.9	-3.47	6.75	6.93	14.96	10.83
Net Income to Common Margin (%)	-12.2	-22.84	-32.15	-17.88	-19.31	-56.43	-8.91	-5.18	-1.4	45.9	-3.47	6.75	6.93	14.96	10.83
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.36	11.09	21.21	27.69
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-7.22	-12.78	-14.97	-9.34	-8.75	-24.39	-4.2	-2.67	-0.78	23.63	-1.53	3.19	3.51	8.05	5.94

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	348	348	656	643	662	683	1,174	830	859	1,087	1,090	1,093	1,096	603	606
ST Debt	- -	23	- -	- -	- -	22	361	- -	373	12	10	10	503	8	9
LT Debt	348	325	656	643	662	661	814	830	486	1,075	1,079	1,083	593	595	597
Total Debt/EBITDA	301.32	-5.29	-5.46	-13.67	-10.43	-0.97	16.05	-29.81	177.33	17.61	42.4	4.16	3.78	1.04	1.24
Net Debt/EBITDA	261.29	-2.55	-0.72	4.95	-4.18	-0.39	7.88	-12.08	84.8	6.9	19.14	1.36	1.14	-0.6	-1.46
Total Debt/EBIT	-10.28	-3.16	-4.2	-6.92	-5.98	-0.85	-79.9	-6.72	-8.55	-25.02	-13.23	6.79	5.9	1.24	1.48
Net Debt/EBIT	-8.91	-1.52	-0.56	2.5	-2.4	-0.34	-39.21	-2.72	-4.09	-9.81	-5.97	2.23	1.79	-0.72	-1.74
EBITDA to Interest Expense	0.14	-9.86	-12.8	-1.41	-1.82	-19.55	1.88	-0.64	0.23	2.25	1.74	19.03	16.74	45.84	44.87
EBITDA-CapEx/Interest Expense	-18.2	-16.54	-19.76	-4.93	-8.33	-23.66	-3.23	-3.95	-7.4	-2.76	-6.34	9.51	10.53	38.15	34.69
EBIT to Interest Expense	-4.03	-16.5	-16.55	-4.82	-8.05	-5.65	-3.58	-3.55	-4.89	-3.34	-5.04	4.16	10.72	37.44	37.57
Interest Expense	8	7	9	33	35	36	39	44	21	27	15	14	17	13	11
Common Equity/Total Assets	59.21	64.77	59.76	61.72	64.38	68.75	60.62	67.04	66.57	70.21	71.04	72.21	72.37	80.96	80.16
Long-Term Debt/Equity (%)	45.06	31.98	48.88	42.08	27.59	23.89	28.96	27.98	15.57	26.18	25.3	23.53	11.98	10.52	9.81
Long-Term Debt/Capital (%)	31.06	23.82	32.83	29.62	21.62	19.16	20.42	21.86	12.21	20.7	20.15	19.01	9.81	9.51	8.92
Long-Term Debt/Total Assets (%)	26.68	20.71	29.21	25.97	17.76	16.42	17.56	18.76	10.37	18.38	17.97	16.99	8.67	8.52	7.86
Total Debt/Equity (%)	45.06	34.28	48.88	42.08	27.59	24.7	41.82	27.98	27.51	26.47	25.54	23.75	22.13	10.65	9.95
Total Debt/Capital (%)	31.06	25.53	32.83	29.62	21.62	19.81	29.49	21.86	21.57	20.93	20.35	19.19	18.12	9.63	9.05
Total Debt/Total Assets (%)	26.68	22.2	29.21	25.97	17.76	16.98	25.35	18.76	18.31	18.59	18.14	17.15	16.02	8.62	7.98
Net Debt to Equity	39.07	16.51	6.47	-15.22	11.05	9.94	20.52	11.34	13.15	10.37	11.53	7.79	6.7	-6.15	-11.74
Net Debt/Capital (%)	28.1	14.17	6.08	-17.96	9.95	9.04	17.03	10.18	11.59	9.38	10.31	7.21	6.27	-6.54	-13.28
EBITDA	1	-66	-120	-47	-64	-707	73	-28	5	62	26	263	290	581	489
EBITDA-CapEx	-153	-110	-185	-164	-291	-855	-126	-172	-159	-76	-94	131	183	483	378
Operating Income (Loss)	-34	-110	-155	-160	-281	-204	-140	-155	-105	-92	-74	57	186	474	409

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.07	2.63	4.28	4.01	1.33	1.8	1.71	2.07	0.81	2.16	1.86	2.19	0.91	1.87	2.06
Current Ratio	4.99	4.36	6.21	5.93	2.45	3.24	2.7	3.93	2.08	4.76	4.16	4.67	2.51	5.33	5.21
Quick Ratio	3.19	3.27	4.99	4.86	1.7	2.29	2.03	2.73	1.21	3.07	2.54	2.98	1.45	2.96	3.25
CFO/Avg Current Liab	0.21	0.13	-0.32	-0.34	-0.64	-0.52	-0.01	0.03	0.07	0.12	0.59	0.31	0.18	0.64	1.21
Common Equity/Total Assets	59.21	64.77	59.76	61.72	64.38	68.75	60.62	67.04	66.57	70.21	71.04	72.21	72.37	80.96	80.16
Long-Term Debt/Equity (%)	45.06	31.98	48.88	42.08	27.59	23.89	28.96	27.98	15.57	26.18	25.3	23.53	11.98	10.52	9.81
Long-Term Debt/Capital (%)	31.06	23.82	32.83	29.62	21.62	19.16	20.42	21.86	12.21	20.7	20.15	19.01	9.81	9.51	8.92
Long-Term Debt/Total Assets (%)	26.68	20.71	29.21	25.97	17.76	16.42	17.56	18.76	10.37	18.38	17.97	16.99	8.67	8.52	7.86
Total Debt/Equity (%)	45.06	34.28	48.88	42.08	27.59	24.7	41.82	27.98	27.51	26.47	25.54	23.75	22.13	10.65	9.95
Total Debt/Capital (%)	31.06	25.53	32.83	29.62	21.62	19.81	29.49	21.86	21.57	20.93	20.35	19.19	18.12	9.63	9.05
Total Debt/Total Assets (%)	26.68	22.2	29.21	25.97	17.76	16.98	25.35	18.76	18.31	18.59	18.14	17.15	16.02	8.62	7.98
CFO/Total Liabilities	3.46	3.19	-6.35	-7.43	-16.52	-18.12	-0.48	1.38	3.08	4.9	17.51	9.93	8.43	43.04	54.94
CFO/CapEx	0.12	0.4	-0.88	-0.6	-0.96	-1.54	-0.04	0.14	0.3	0.62	2.55	1.34	1.48	5.88	7.46
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	5.85	5.95	6.11	7.46	5.44	8.47	5.38

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.61	4.68	4.83	5.71	5.75	5.87	5.51	4.94	4.73	4.51	4.49	5.02	4.42	4.41	4.11
Days Sales Outstanding	79.15	77.96	75.49	63.89	63.46	62.13	66.22	73.92	77.11	81	81.23	72.68	82.61	82.76	88.88
Inventory Turnover	0.7	0.71	0.61	0.68	0.65	0.67	0.58	0.63	0.59	0.76	0.64	0.6	0.53	0.5	0.57
Days Inventory Outstanding	520.89	514.36	601.44	540.42	565.64	545.71	627.16	582.73	614.9	479.97	572.2	606.16	686.44	735.94	643.96
Accounts Payable Turnover	5.09	1.75	1.51	1.36	1.41	1.58	2.02	1.98	2.27	2.51	2.81	2.88	2.73	2.56	2.86
Accounts Payable Turnover Days	71.72	208.4	242.41	269.33	259.47	230.81	180.25	184.41	160.89	145.45	130.1	126.75	133.91	142.47	127.66
Cash Conversion Cycle	528.32	383.92	434.53	334.98	369.63	377.03	513.13	472.23	531.13	415.52	523.33	552.08	635.14	676.24	605.18
Inventory to Cash Days	-441.74	-436.39	-525.95	-476.53	-502.18	-483.58	-560.95	-508.81	-537.78	-398.97	-490.97	-533.48	-603.84	-653.18	-555.08
Inventories	130	129	163	199	272	355	476	531	680	699	777	894	1,107	1,233	1,299
Raw Materials	12	12	15	22	46	51	50	75	74	77	80	131	156	154	107
Work In Process	76	71	88	114	150	168	235	231	350	308	415	411	571	551	801
Finished Goods	42	45	59	63	75	136	191	225	256	314	281	352	380	528	391
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	15,186	15,857	16,454	20,111	15,014	16,322	10,490
- Cash & Cash Equivalents	46	181	569	875	397	408	598	494	437	649	587	725	755	943	1,312
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	348	348	656	643	662	683	1,174	830	859	1,087	1,090	1,093	1,096	603	606
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	15,291	15,878	16,530	19,913	15,036	15,787	9,535
Total Capital	1,121	1,364	1,997	2,171	3,063	3,450	3,983	3,798	3,981	5,193	5,355	5,697	6,047	6,261	6,693
Total Debt/Capital (%)	31.06	25.53	32.83	29.62	21.62	19.81	29.49	21.86	21.57	20.93	20.35	19.19	18.12	9.63	9.05
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.06	0.07	0.07	0.05	0.07	0.04	0.06
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	8.97	8.53	8.95	9.5	6.22	5.53	2.96
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	3,157.36	257.22	643.24	75.73	51.82	27.19	19.5
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	123.7	80.94	32.6	23.29
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	105.37	86.08	27.09	11.41
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	346.7	224.22	32.52	13.15
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	15,119	16,724	16,359	20,404	15,253	16,831	10,768
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	15,224	16,745	16,435	20,206	15,275	16,296	9,813
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	85.03	87.37	89.88	106.91	79.72	82.76	49.59
TTM Sales	441	501	548	749	890	1,117	1,314	1,491	1,704	1,860	1,846	2,096	2,419	2,854	3,221
TTM EBITDA	1	-66	-120	-47	-64	-707	73	-28	5	62	26	263	290	581	489
TTM Operating Income	-34	-110	-155	-160	-281	-204	-140	-155	-105	-92	-74	57	186	474	409
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	189	175	583	836
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	57	67	485	725

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	-131.3	-320.67	88.28	459.94	295.32	35.4	15.02
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	123.7	80.94	32.6	23.29
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	15,291	15,878	16,530	19,913	15,036	15,787	9,535
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	65.81	73.15	72.21	73.75	78.39	82.08	53.44
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	8.97	8.53	8.95	9.5	6.22	5.53	2.96
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	3,157.36	257.22	643.24	75.73	51.82	27.19	19.5
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.47	- -	141.32	89.2	38.09	29.99
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.7	- -	114.14	104.48	39.87	32.37
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	26.96	- -	141.32	126.25	40.99	41.57
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.49	- -	96.52	87.83	36.54	29.38
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	4.86	3.86	3.86	4.37	3.03	2.88	1.72
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	4.51	3.91	3.51	3.53	3.55	3.02	1.86
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	4.87	5.64	3.96	4.37	4.29	3.1	2.39
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	3.79	3.24	3.11	2.98	2.99	2.77	1.69
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	6.15	4.54	4.47	4.94	3.37	3.13	1.85
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	5.7	4.6	4.06	3.99	3.94	3.28	1.99
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	6.16	6.63	4.59	4.94	4.76	3.37	2.56
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	4.79	3.81	3.61	3.38	3.31	3.01	1.81
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	8.87	8.48	8.86	9.54	6.18	5.7	3.25
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	8.22	8.59	8.05	7.71	7.24	5.96	3.51
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	8.89	12.38	9.11	9.54	8.75	6.13	4.5
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	6.91	7.11	7.15	6.52	6.09	5.47	3.18
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	313.26	184.8	53.72	113.73	93.89	28.38	12.64
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	290.22	187.13	48.83	91.86	109.98	29.71	13.64
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	313.83	269.77	55.22	113.73	132.89	30.54	17.52
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	244.13	154.93	43.36	77.68	92.45	27.23	12.38
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	-121.64	-324.71	80.25	371.49	345.91	37.06	16.21
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	-131.54	-468.11	90.74	459.94	417.99	38.1	20.82
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	-102.33	-268.84	71.26	314.15	290.79	33.96	14.71
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	8.32	8.64	8.14	7.66	7.28	5.8	3.22
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	8.99	12.45	9.2	9.5	8.79	5.97	4.22
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	7.01	7.16	7.23	6.46	6.12	5.3	2.89
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	2,926.68	260.46	585	61.02	60.68	28.5	21.2
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	3,163.06	375.33	661.1	75.73	73.31	29.33	27.79
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	2,465.37	215.7	519.76	51.49	51.03	26.05	19.06
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	99.68	94.78	34.18	25.32
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	123.7	114.51	35.17	33.18
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	84.1	79.7	31.23	22.77
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	84.44	87.25	89.47	107.98	79.61	85.56	54.55
High Price	- -	- -	- -	- -	- -	- -	- -	- -	84.6	127.37	91.96	107.98	112.68	92.08	75.63
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	14,174	16,079	15,033	16,046	17,608	16,550	10,368
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	15,319	23,170	16,989	19,913	21,273	17,030	13,588
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	11,940	13,316	13,357	13,538	14,806	15,123	9,322

Shares Outstanding	115	126	143	149	162	173	176	178	180	182	184	186	189	191	192
Diluted Weighted Avg Shares	112	120	138	146	160	166	174	177	179	192	183	189	192	197	197
Basic Weighted Avg Shares	112	120	138	146	160	166	174	177	179	181	183	185	188	190	192
Revenue per Share	3.94	4.16	3.98	5.12	5.56	6.73	7.53	8.42	9.52	10.29	10.1	11.31	12.88	15.02	16.8
EBITDA per Share	0.01	-0.55	-0.87	-0.32	-0.4	-4.26	0.42	-0.16	0.03	0.34	0.14	1.42	1.54	3.06	2.55
Operating Income per Share	-0.3	-0.92	-1.13	-1.1	-1.76	-1.23	-0.8	-0.88	-0.59	-0.51	-0.41	0.31	0.99	2.5	2.14
Basic EPS, GAAP	-0.48	-0.95	-1.28	-0.92	-1.07	-3.8	-0.67	-0.44	-0.13	4.72	-0.35	0.76	0.89	2.25	1.82
Basic EPS from Cont Ops	-0.48	-0.95	-1.28	-0.92	-1.07	-3.8	-0.67	-0.44	-0.13	4.72	-0.35	0.76	0.89	2.25	1.82
Diluted EPS, GAAP	-0.48	-0.95	-1.28	-0.92	-1.07	-3.79	-0.67	-0.44	-0.13	4.46	-0.35	0.75	0.87	2.17	1.77
Diluted EPS from Cont Ops	-0.48	-0.95	-1.28	-0.92	-1.07	-3.79	-0.67	-0.44	-0.13	4.46	-0.35	0.75	0.87	2.17	1.77
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.16	0.15	-0.42	-0.48	-1.37	-1.37	-0.05	0.11	0.27	0.47	1.67	0.95	0.85	3.01	4.32
Free Cash Flow per Basic Share	-1.21	-0.22	-0.89	-1.28	-2.79	-2.27	-1.19	-0.7	-0.64	-0.29	1.01	0.24	0.27	2.5	3.74
Cash & Equivalents per Share	1.7	3.56	5.47	6.34	3.67	4.57	7.94	6.08	4.19	5.86	5.51	6.93	5.69	5.96	8.12
Book Value per Share	6.73	8.07	9.35	10.25	14.86	16.02	15.97	16.65	17.36	22.59	23.19	24.71	26.25	29.66	31.65
Tangible Book Value per Share	4.71	6.37	7.83	8.83	9.41	11.67	11.91	12.79	13.73	19.22	20.01	21.84	23.65	27.29	29.52

BioMarin Pharmaceutical Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)